Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis

Research output: Contribution to journalReview articlepeer-review

9 Scopus citations


Immunoglobulin light chain amyloidosis is the most common type of systemic amyloidosis. Hematopoietic stem cell transplantation (HCT) is an effective treatment option for AL however due to multi-organ involvement in this disease HCT is feasible in a minority of patients. To maximize the benefit and minimize toxicity it is of paramount importance to optimize the selection of patients for HCT. In this review we discuss evolution of HCT and its typical application to a case of AL amyloidosis.

Original languageEnglish (US)
Pages (from-to)796-801
Number of pages6
JournalBiology of Blood and Marrow Transplantation
Issue number5
StatePublished - May 1 2016


  • AL amyloidosis
  • Hematopoeitic stem cell transplantation
  • Immunoglobulin light chain amyloidosis
  • Stem cell transplantation

ASJC Scopus subject areas

  • Hematology
  • Transplantation


Dive into the research topics of 'Evolution of Hematopoietic Cell Transplantation for Immunoglobulin Light Chain Amyloidosis'. Together they form a unique fingerprint.

Cite this